Recorded at SCbio’s 2025 annual conference, Heather and Lauren welcome Eric Perrault, the CEO of Kiyatec, a company focused on functional precision oncology. Eric discusses their exciting process, which aims to predict how individual cancer patients will respond to tailored therapies before treatment even begins. We dive into their live cell therapy, partnerships with surgeons, and much more. Tune in to learn about cutting-edge developments in personalized cancer treatment!
